It's World Cancer Day
Published in Cancer

This Q&A accompanies an Editorial published in Biological Procedures Online to raise awareness for World Cancer Day, co-authored by Editor-in-Chief, Bolin Liu, and Hamed Kioumarsi.
Hamed Kioumarsi received his BSc and MSc degrees in Agriculture and his Ph.D. from the University of Science Malaysia in 2004, 2007, and 2011, respectively. He later completed a second Master’s degree in Education (Applied Linguistics). He is an award-winning author, researcher, and education consultant.
Could you tell me a bit about yourself and your roles at Biological Procedures Online and Hereditas journals? How does your research connect to the celebration of World Cancer Day?
Over the past several years, I have worked as an Associate Editor and Editorial Board Member for leading Springer Nature journals. Much of the research published in these journals directly and indirectly contributes to global education and health initiatives, including those focused on preventing critical diseases like cancer, which aligns with the Sustainable Development Goals (SDGs).
To address the significant challenges facing the world today, we need shared objectives, motivation, and collaborative strategies. Aligning science and education with the SDGs — driven by the major environmental and social issues of our time — can help us create the better world we envision, while ensuring we maintain hope for a brighter future.
What is the significance of World Cancer Day, and how does it contribute to the global fight against cancer?
World Cancer Day is an International Day of Awareness and a movement focused on the prevention, early detection, and treatment of cancer. This day was created to unite the world by emphasizing education, screening, and support for all those affected by the disease.
Basic cancer research and education contribute to achieving SDG4 by increasing global awareness of cancer. Various educational programs have been successful in enhancing knowledge of cancer risk factors and symptoms, as well as promoting helpful early intervention actions worldwide.
How do you think World Cancer Day contributes to raising global awareness about cancer and its impact on health, aligning with SDG 3, Good Health and Well-being?
World Cancer Day plays a crucial role in raising awareness about cancer worldwide. It advocates for SDG3, which focuses on equal opportunities for the prevention and management of cancer. In fact, it serves as a call to action to reduce cancer-related deaths, particularly in low- and middle-income countries, where the burden is greatest. Organizations like the World Health Organization (WHO) are working tirelessly to map the way forward, alongside charities dedicated to this noble cause. The initiative emphasizes informed health decisions, paired with early detection, to ensure better outcomes across all communities.
How do you think World Cancer Day has helped raise awareness about cancer prevention and early detection?
World Cancer Day highlights the importance of cancer prevention and the vast potential of early detection. It serves as a call for global action and commitment to ensuring that education about the risks and symptoms of cancer is accessible. Efforts to promote screening and prevention programs should be undertaken collectively to reduce new cases.
How has cancer research evolved over the past decade, and what breakthroughs do you anticipate in the near future?
The last decade has seen diverse discoveries in cancer research, including AI and machine learning in diagnosis, nanomedicines, combination therapies, drug repurposing, and personalized treatments. Looking to the future, these advances will combine both old and new approaches, with the use of artificial intelligence playing a key role in better understanding cancer and responses to the disease.
World Cancer Day calls for collaboration across sectors. How can partnerships between governments, private organizations, and civil society contribute to achieving SDG 17 (Partnerships for the Goals) in cancer prevention and care?
There is a need for partnerships between governments, the private sector, and civil society to advance the cause of cancer prevention and care. Such partnerships will provide a path to share resources, knowledge, and innovation in response to inequalities in cancer care. This policy can be a team effort, effectively implemented through collaborations involving various stakeholders, increasing access to treatment, and providing funding for different cancer programs.
What advice would you give to individuals who are looking to get involved in cancer awareness or research initiatives?
Try to work with diverse organizations and participate in events and fundraising activities. You can advocate for cancer awareness and push for more funding to be directed toward research in your community, nationally, and globally.
Follow the Topic
-
Biological Procedures Online
Biological Procedures Online publishes articles that enhance access to techniques and improve basic understanding of medical and biological sciences. Interests include research discoveries in technology development, animal models of human diseases, and cancer biology and therapeutic approaches.
-
Hereditas
Hereditas publishes original cutting-edge research and reviews. The journal welcomes research from across all areas of human, plant, animal and microbial genetics and epigenetics. Topics of interest also include cancer genetics, cancer biology, non-coding RNA, Data Mining, and Genome Technology.
Related Collections
With collections, you can get published faster and increase your visibility.
Cancer Therapy and Immunotherapy: Challenges and Opportunities
Significant advances have been made in cancer therapy and immunotherapy, including the development of targeted antineoplastic agents, robust tumor cell lines and xenograft models for drug screening, and the exploration of immunological approaches to cancer inhibition. These breakthroughs have provided valuable insights into drug resistance, tumor biology, and the interplay between the immune system and cancer cells. They have also paved the way for innovative immunotherapeutic interventions, such as immune checkpoint inhibitors and CAR T-cell therapy, revolutionizing cancer treatment paradigms.
Future research may focus on unraveling the molecular mechanisms underlying drug resistance, refining xenograft models and antitumor assays, and identifying novel immunotherapeutic targets for enhanced treatment efficacy. Cutting-edge technologies, such as single-cell sequencing and advanced imaging modalities, are poised to provide unprecedented insights into tumor heterogeneity, immune cell dynamics, and the tumor microenvironment, shaping the next generation of cancer therapies.
This Collection seeks to showcase cutting-edge research in cancer therapy and immunotherapy, focusing on the challenges and opportunities in the development of novel treatment strategies, the exploration of immunological approaches, and the understanding of drug resistance mechanisms. We welcome multidisciplinary approaches integrating novel methodologies from medicine, biology, imaging, engineering, bioinformatics, and system analysis.
All submissions in this collection undergo the journal’s standard peer review process. Similarly, all manuscripts authored by a Guest Editor(s) will be handled by the Editor-in-Chief. As an open access publication, this journal levies an article processing fee (details here). We recognize that many key stakeholders may not have access to such resources and are committed to supporting participation in this issue wherever resources are a barrier. For more information about what support may be available, please visit OA funding and support, or email OAfundingpolicy@springernature.com or the Editor-in-Chief.
Publishing Model: Open Access
Deadline: Sep 22, 2025
Current and novel therapeutic approaches to gastrointestinal cancers
Gastrointestinal cancers include a wide range of carcinomas including hepatocellular, cholangiocarcinoma, colorectal, colorectal metastasis to liver, gastric, pancreatic, and rectal. This Collection aims to highlight current and novel therapeutic approaches to treat gastrointestinal cancers with a focus on targeted locoregional therapy, chemotherapy, immunotherapy, combinational therapies, and genomic advancements to aid in personalized treatment approaches.
All submissions in this collection undergo the journal’s standard peer review process. Similarly, all manuscripts authored by a Guest Editor(s) will be handled by the Editor-in-Chief. As an open access publication, this journal levies an article processing fee (details here). We recognize that many key stakeholders may not have access to such resources and are committed to supporting participation in this issue wherever resources are a barrier. For more information about what support may be available, please visit OA funding and support, or email OAfundingpolicy@springernature.com or the Editor-in-Chief.
Publishing Model: Open Access
Deadline: Mar 07, 2026
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in